Extrawell Pharmaceutical Holdings Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was HKD 72.58 million compared to HKD 73.93 million a year ago. Net income was HKD 129.27 million compared to HKD 130.59 million a year ago.

Basic earnings per share from continuing operations was HKD 0.0541 compared to HKD 0.0546 a year ago. Diluted earnings per share from continuing operations was HKD 0.044 compared to HKD 0.0436 a year ago.